CVS

CVS HEALTH Corp
—

Company Information

Company Name
CVS HEALTH Corp
CIK
CIK0000064803
Category
Large accelerated filer
Ticker: Exchange
CVS: NYSE
Fiscal Year End
December 31
Owner Organization
07 Trade & Services
SIC
5912
SIC Description
Retail-Drug Stores and Proprietary Stores
Ticker
CVS

SEC filing data through

Insider Sentiment

Last purchase
2025-06-05
Last sale
2026-05-21
Shares purchased (TTM)
1,570
Shares sold (TTM)
447,513
Buy ratio (TTM)0.3%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
1,101,730,508
Shares outstanding
1,279,000,000
Ownership
86.14%
+3.32% Y/Y

Earnings Market Reaction

Filing date
2026-08-05
Price on filing date
—
1-month reaction
-6.11%
3-month reaction
…
Drift continued7/11 (64%)
Faded / reversed4/11 (36%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Cash And Cash Equivalents At Carrying Value11,3299,5428,4539,09811,78710,0768,5866,87512,5079,8018,19613,043
Short Term Investments2,6292,2602,1452,1342,3862,5782,4072,8053,7553,2883,2593,145
Accounts Receivable Net Current40,30940,99239,77943,85740,65139,62536,46936,17932,38532,21735,22732,927
Inventory Net17,62217,77019,24618,96217,44717,38518,10717,64916,06816,34618,02517,954
Assets Of Disposal Group Including Discontinued Operation Current----------00
Other Assets Current3,4574,2535,0913,0583,3783,5273,0763,8355,2375,8213,1513,074
Assets Current75,34674,81774,71477,10975,64973,19168,64567,34369,95267,47367,85870,143
Long Term Investments33,24732,40732,66931,55329,85828,90628,93428,93925,02824,07423,01921,667
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization13,16813,03713,08312,83812,82512,85612,99312,72813,03213,03713,18313,022
Operating Lease Right Of Use Asset14,45114,74114,97315,27115,51215,70415,94416,23116,90117,04517,25217,564
Goodwill85,47885,47885,47885,47891,20391,20391,27291,27291,27291,27291,27291,261
Intangible Assets Net Excluding Goodwill24,64425,07025,50825,98426,22426,57027,32327,81728,31128,77029,23429,624
Separate Account Assets--1,9941,9341,8581,9243,3113,3343,1873,2713,2503,200
Other Assets Noncurrent7,4347,4245,1195,1605,2145,2314,7934,7634,7984,8014,6604,825
Assets253,768252,974253,538255,327258,343255,585253,215252,427252,481249,743249,728251,306
Liabilities
Accounts Payable Trade Current17,16716,92217,64117,76417,25816,53415,89215,71314,41613,71714,89714,874
Liability For Claims And Claims Adjustment Expense-----------12,550
Other Policyholder Funds-------9131,0511,0811,3261,440
Accrued Liabilities Current22,47722,25822,38723,41523,10122,36920,81020,17421,16322,35023,51522,571
Operating Lease Liability Current1,9141,9041,7371,9091,9061,9091,7511,9121,9111,9061,7411,741
Short Term Borrowings--01,2473,0401,2592,11980002,719200-
Long Term Debt And Capital Lease Obligations Current1,9582,5804,0684,0816,1604,4113,6244,9103,7313,7312,7722,132
Liabilities Current87,04186,40688,69292,69594,16288,96184,60984,62781,38683,31979,18981,553
Operating Lease Liability Noncurrent12,98213,33013,64314,00714,32814,59414,89915,25815,53715,74216,03416,441
Long Term Debt And Capital Lease Obligations59,45260,53160,50260,50857,29059,04060,52759,82462,64357,69458,63859,782
Deferred Income Tax Liabilities Net3,7663,7713,8323,5473,6033,6643,8063,6324,0524,1844,3114,250
Liabilities Of Disposal Group Including Discontinued Operation Current----------00
Separate Accounts Liability--1,9941,9341,8581,9243,3113,3343,1873,2713,2503,200
Other Liabilities Noncurrent6,1126,7074,7774,7594,7825,4195,4315,4845,5266,2056,2116,237
Liabilities173,869175,337178,156182,217180,792178,475177,485177,321177,370175,593173,092176,796
Stockholders Equity
Preferred Stock Value000000000000
Common Stocks Including Additional Paid In Capital50,96850,67950,40250,18150,02049,83749,66149,51049,37149,20948,99248,829
Treasury Stock Common Value-36,852-36,706-36,790-36,776-36,849-36,735-36,818-36,813-36,919-36,773-33,838-33,831
Retained Earnings Accumulated Deficit65,39863,28261,19659,10763,93663,76862,83762,03862,79761,87361,60460,343
Accumulated Other Comprehensive Income Loss Net Of Tax18820140641627259-120209-319-341-297-1,004
Stockholders Equity79,70277,63775,21473,11077,55176,92975,56075,10674,93074,15076,46174,510
Minority Interest197181168182172181170162181182175173
Liabilities And Stockholders Equity253,768252,974253,538255,327258,343255,585253,215252,427252,481249,743249,728251,306
Preferred Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized000000000000
Preferred Stock Shares Issued000000000000
Preferred Stock Shares Outstanding000000000000
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized3,2003,2003,2003,2003,2003,2003,2003,2003,2003,2003,2003,200
Common Stock Shares Issued1,7951,7881,7871,7861,7851,7791,7781,7771,7771,7711,7681,767
Shares Outstanding1,2781,2731,2711,2701,2671,2621,2601,2581,2561,2521,2881,287
Treasury Stock Common Shares517515516516518517518519521519480480

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

CVS HEALTH Corp (CVS) — SEC Financial Statements & Analysis

CVS HEALTH Corp (CVS) is a retail-drug stores and proprietary stores company, incorporated in DE. CVS HEALTH Corp trades on NYSE as: CVS. CVS HEALTH Corp (CVS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, CVS HEALTH Corp carries a market cap of $131.50B, a P/E ratio of 27.00x, a P/B ratio of 1.65x, a P/S ratio of 0.59x, an enterprise value of $181.37B, and an EV/EBITDA multiple of 14.16x. On profitability, it posts a gross margin of -3.90%, an operating margin of 3.74%, a net margin of 2.20%, a Return on Equity (ROE) of 6.20%, a Return on Assets (ROA) of 1.90%, and a Return on Invested Capital (ROIC) of 5.11%. Per share, it reports EPS of $3.81, diluted EPS of $3.78, free cash flow per share of $9.19, and a dividend per share of $2.67. Over the trailing year, it posted revenue growth of -42.36% year-over-year, net income growth of 8.56% year-over-year, and EPS growth of 7.45% year-over-year. On the balance sheet, it maintains a current ratio of 0.87x, a quick ratio of 0.66x, working capital of $-11.70B, a debt-to-equity ratio of 2.18x, a debt ratio of 0.69, an interest coverage ratio of 2.67x, free cash flow of $11.76B (TTM), and net debt of $49.87B. Figures sourced from SEC EDGAR.

Market Cap
$131.50B
P/E TTM
27.00x
EPS TTM
$3.81
P/B TTM
1.65x
ROE TTM
6.20%
ROA TTM
1.90%
Debt To Equity
2.18x
Free Cash Flow TTM
$11.76B
Net Revenue TTM Growth 1Y
-42.36%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CVS HEALTH Corp in?

CVS HEALTH Corp (CVS) operates in the Retail-Drug Stores and Proprietary Stores industry.

What exchange does CVS trade on?

CVS HEALTH Corp (CVS) trades on the NYSE.

Where is CVS HEALTH Corp incorporated?

CVS HEALTH Corp is incorporated in DE.

When was CVS HEALTH Corp (CVS)'s most recent SEC filing?

CVS HEALTH Corp (CVS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.

What is CVS's market cap?

CVS HEALTH Corp (CVS) has a market capitalization of $131.50B as of 2026-06-30.

What is CVS's P/E ratio?

CVS HEALTH Corp (CVS)'s trailing twelve month P/E ratio is 27.00x as of 2026-06-30.

What is CVS's EPS (earnings per share)?

CVS HEALTH Corp (CVS)'s trailing twelve month EPS is $3.81 as of 2026-06-30.

What is CVS's ROE (return on equity)?

CVS HEALTH Corp (CVS)'s trailing twelve month Return on Equity (ROE) is 6.20% as of 2026-06-30.

What is CVS's ROA (return on assets)?

CVS HEALTH Corp (CVS)'s trailing twelve month Return on Assets (ROA) is 1.90% as of 2026-06-30.

What is CVS's ROIC (return on invested capital)?

CVS HEALTH Corp (CVS)'s trailing twelve month Return on Invested Capital (ROIC) is 5.11% as of 2026-06-30.

What is CVS's EV/EBITDA?

CVS HEALTH Corp (CVS)'s trailing twelve month EV/EBITDA is 14.16x as of 2026-06-30.

Wall Street's data.
Main Street's price.